Search

Find exactly what you’re looking for.
Search

Service
Showing 21-35 of 35 results

Saul Ewing LLP, a full-service national law firm, is proud to announce that the WTR 1000 – The World’s Leading Trademark Professionals has recognized Partners Darius Gambino and Sherry Flax in its 2023 edition. Now in its 13th year, the WTR 1000 directory is dedicated exclusively to identifying the...

​The FTC has announced the annual updates to the Hart-Scott-Rodino (“HSR”) size thresholds, fees and the daily penalty for HSR violations. The updated thresholds and fees were published in the Federal Register on January 26, 2023 and will take effect on February 27, 2023. See Federal Register...
LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...

The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

Attorney and host of the “Lawyers With Game” video podcast, Darius Gambino discuses The Ohio State University's trademark of the word "The" with NBC Legal Analyst Danny Cevallos on the Michael Smerconish Program, Tuesday 28 June 2022.

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

For More Information
Contact us